Respiratory syncytial virus (RSV) causes respiratory infections in humans. What Are the Symptoms of RSV Infection? In most people, RSV causes mild cold-like symptoms of cough, runny nose, sore throat, headache, decreased appetite, and fever that typically last less than 5 days. However, in older adults, RSV can cause […]
Clinical trials show that a single injection of nirsevimab significantly reduces severe illness from respiratory syncytial virus, which sickens millions of kids each year. Nearly all children will be infected by respiratory syncytial virus, or RSV, by the time they turn 2. Most experience common cold symptoms and recover within […]
Approved by the FDA, the vaccine will soon be available for adults 60 or older Respiratory syncytial virus, known as RSV, is a lung infection that’s highly contagious. “RSV is the poster child for what’s called paramyxoviruses, which is a family of viruses that can cause mild infections,” says pediatric […]
After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on the way. On Wednesday, the US Food and Drug Administration approved Arexvy, made by GSK, which is designed to be given as a single shot to […]
Before 2020, annual respiratory syncytial virus (RSV) epidemics tended to begin in October, peak in December, and end by April. But patterns changed after the pandemic began, according to US Centers for Disease Control and Prevention data collected between 2017 and 2023. No typical winter RSV epidemic occurred during 2020-2021. […]
Actualizaciones sobre el virus respiratorio sincitial (VRS), incluidas las herramientas de diagnóstico y las opciones de tratamiento El virus respiratorio sincitial, o VRS, es universalmente reconocido como una de las causas más cruciales y comunes de enfermedad infantil. Su impacto en los ancianos es igualmente perjudicial. Antes de la pandemia […]
Las infecciones por el VRS pueden ser peligrosas para ciertos adultos. Cada año, se estima que en los Estados Unidos entre 60 000 a 120 000 adultos mayores son hospitalizados y entre 6 000 a 10 000 de ellos mueren debido a una infección por el VRS. Los adultos que tienen el […]
